M/S. FORTUNE GENERIX PHARMA LLP THROUGH ITS PARTNERS ASHWIN SHIVKUMAR SIRASLEWALA v. CENTRAL BANK OF INDIA
SCA/1237/2026 · 2026-02-02
Aniruddha P Mayee
body2026
DailyLaw.ai
[ 2026 DAILYLAW 5133 (GUJ) · dailylaw.ai ]
DailyLaw.ai
[ 2026 DAILYLAW 5133 (GUJ) · dailylaw.ai ]
Judgment text
Extracted from the PDF above. The PDF is authoritative.
C/SCA/1237/2026 ORDER DATED: 02/02/2026 IN THE HIGH COURT OF GUJARAT AT AHMEDABAD R/SPECIAL CIVIL APPLICATION NO. 1237 of 2026 ================================================================ M/S. FORTUNE GENERIX PHARMA LLP THROUGH ITS PARTNERS ASHWIN SHIVKUMAR SIRASLEWALA & ORS. Versus CENTRAL BANK OF INDIA & ORS. ================================================================ Appearance: RITESH D PATADIA(6460) for the Petitioner(s) No. 1,2,3 MR PR ABICHANDANI(102) for the Respondent(s) No. 3,4 MR RAJESH K KANANI(2157) for the Respondent(s) No. 1 ================================================================
CORAM:HONOURABLE MR. JUSTICE ANIRUDDHA P. MAYEE
Date : 02/02/2026 ORAL ORDER
Learned counsel Ms.Riddhi Vadgama on behalf of learned advocate Mr.Ritesh D. Patadia for the petitioners submits that due to subsequent events, she may be permitted to withdraw the present petition. Permission is granted. The present petition stands dismissed as withdrawn.
Learned counsel Mr.Sandip C. Bhatt is permitted to file vakalatnama on behalf of respondent no.1-Central Bank of India. Sd/- (ANIRUDDHA P. MAYEE, J.) ABHISHEK/SB-4